Transition Therapeutics to Hold Conference Call on Second Quarter Fiscal 2010 Financial Results on Wednesday, February 10th, at 4:30 P.M. EST
08. Februar 2010 07:01 ET
|
Transition Therapeutics Inc.
TORONTO, Feb. 8, 2010 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. ("Transition" or the "Company") (Nasdaq:TTHI) (TSX:TTH) will hold a conference call on Wednesday, February 10, 2010 at 4:30 P.M....
Transition Therapeutics Announces Participation in 12th Annual BIO CEO & Investor Conference
05. Februar 2010 13:31 ET
|
Transition Therapeutics Inc.
TORONTO, Feb. 5, 2010 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. ("Transition" or the "Company") (Nasdaq:TTHI) (TSX:TTH) today announced that Dr. Tony Cruz, Chairman and Chief Executive Officer,...
Transition Therapeutics Announces Results of a Phase 2 Study of TT-223 in Type 2 Diabetes Patients
25. Januar 2010 06:01 ET
|
Transition Therapeutics Inc.
TORONTO, Jan. 25, 2010 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. ("Transition" or the "Company") (TSX:TTH) (Nasdaq:TTHI) today announced the results from a Phase 2 clinical study of gastrin...
Transition Therapeutics Announces First Quarter Fiscal 2010 Financial Results
10. November 2009 16:00 ET
|
Transition Therapeutics Inc.
TORONTO, Nov. 10, 2009 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. ("Transition" or the "Company") (TSX:TTH) (Nasdaq:TTHI), a product-focused biopharmaceutical company developing therapeutics for...
Transition Therapeutics to Hold Conference Call on First Quarter Fiscal 2010 Financial Results on Tuesday, November 10th, at 4:30 P.M. EST
06. November 2009 15:06 ET
|
Transition Therapeutics Inc.
TORONTO, Nov. 6, 2009 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. ("Transition" or the "Company") (Nasdaq:TTHI) (TSX:TTH) will hold a conference call on Tuesday, November 10, 2009 at 4:30 P.M....
Transition Therapeutics Files Shelf Registration Statement
29. September 2009 15:20 ET
|
Transition Therapeutics Inc.
TORONTO, Sept. 29, 2009 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. ("Transition" or the "Company") (Nasdaq:TTHI) (TSX:TTH) today announced that it has filed a preliminary short form base shelf...
Transition Therapeutics Announces Fiscal 2009 Year End Financial Results
16. September 2009 16:01 ET
|
Transition Therapeutics Inc.
TORONTO, Sept. 16, 2009 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. ("Transition" or the "Company") (TSX:TTH) (Nasdaq:TTHI), a product-focused biopharmaceutical company developing therapeutics...
Transition Therapeutics to Hold Conference Call On Fiscal Year-End 2009 Financial Results On Wednesday, September 16th, At 4:30 P.M. EDT
15. September 2009 13:15 ET
|
Transition Therapeutics Inc.
TORONTO, Sept. 15, 2009 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. ("Transition" or the "Company") (Nasdaq:TTHI) (TSX:TTH) will hold a conference call on Wednesday, September 16, 2009 at 4:30...
Transition Therapeutics to Present At Rodman and Renshaw 11th Annual Healthcare Conference
10. September 2009 07:01 ET
|
Transition Therapeutics Inc.
TORONTO, Sept. 10, 2009 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. ("Transition" or the "Company") (Nasdaq:TTHI) (TSX:TTH) today announced that Mr. Elie Farah, President and Chief Financial...